As a result of new, more "automated" technology, five nonresectoscopic endometrial ablation techniques were introduced, starting with FDA approval of the thermal balloon
device in 1997.
Uterine endometrial thermal balloon
therapy for the treatment of menorrhagia: long-term multicenter follow-up study.
NATIONAL HARBOR, MD - A thermal balloon
endometrial ablation provided long-lasting benefit to women with dysmenorrhea, with 86% saying the benefits lasted for up to 11 years, and 82% reporting that they needed no further treatment for the condition.
Amongst these techniques Thermal Balloon
Endometrial Ablation (TBEA) is one of the alternatives.
A thermal balloon
for photographing hovered over the Old City which seemed devoid of any young people.
SAN DIEGO -- Thermal balloon
endometrial ablation is a safe and effective option for the treatment of women with idiopathic menorrhagia, results from a 3-year study of 330 women have shown.
Another technique, recommended by the National Institute for Clinical Excellence, involves a fluid-filled thermal balloon
destroying the lining of the uterus.
Another technique - fluid-filled thermal balloon
endometrial ablation - was also recommended for use in the NHS in England and Wales after both methods were judged to be clinically and cost- effective by the watchdog last year.
The report highlights a study showing that the NovaSure System demonstrated higher amenorrhea rates and greater overall patient satisfaction with treatment outcome at 12 months compared to thermal balloon
endometrial ablation (TBEA).
The two most commonly used endometrial ablation devices in this study were thermal balloon
ablation and bipolar radiofrequency ablation.
This technological concept provided the foundation for the first GEA device to be approved by the US Food and Drug Administration (FDA) for clinical use, the Thermachoice Thermal Balloon
Ablation system (Gynecare, Inc) in 1997.
Results of Thermal Balloon
Endometrial Ablation Follow-Up Amenorrhea Hypomenorrhea 6 months (n = 321) 61% 22% 12 months (n = 289) 48% 27% 18 months (n = 193) 42% 31% 24 months (n = 132) 39% 35% 36 months (n = 91) 38% 35% Source: Dr.